Further investigation on the interaction between germline variants and somatic alterations, we and other group found that patients with heterozygous genotype of rs3731249 were tend to loss the expression of wild-type CDKN2A in their leukemia cells, either through loss of heterozygosity or allele-specific post-transcriptional inactivation [14]. This evidence concerns the gene CDKN2A and leukemia.